Z-1497-2026 Class II Ongoing

Recalled by Ion Beam Applications S.A. — Ottignies-Louvain-La-Neuve, N/A

FDA device recall Z-1497-2026 was initiated by Ion Beam Applications S.A. on Feb 3, 2026 and is designated Class II. Reason for recall: It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if… The recall status is ongoing. Affected quantity: 4 units (1 US, 3 OUS).

Recall details

Product Type
Devices
Report Date
Mar 18, 2026
Initiation Date
Feb 3, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
4 units (1 US, 3 OUS)

Product description

IBA Proton Therapy System - PROTEUS 235

Reason for recall

It was identified that eh Universal Beam Triggering Interface (UBTI) is disabled in the Therapy Safety System (TSS) configuration. In this condition, the TSS does not interrupt the beam delivery if the Healthy Signal from an external gating device is lost. This may lead to a risk of mistreatment when external gating devices are used.

Distribution pattern

Worldwide - US Nationwide distribution in the state of FL and the countries of Italy and Japan.

Code information

PROTEUS 235; UDI-DI: 05404013801138; Serial Numbers: SBF103 (JP), SBF124 (EU), SBF133 (US), SBF140 (EU)

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1497-2026
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1497-2026. Report a data issue: hello@regdatalab.com.